Marker Therapeutics Inc (MRKR)

[learningcurve2020]

I think that's right. Wannabe biotech executives and financiers have discovered a pot of gold at the end of the public biotech rainbow, and it has nothing to do with creating a successful drug or biologic.

Unqualified, these execs get to collect very handsome salaries, bonuses and parachutes deals while always knowing the chances of commercializing are next to zero. Then comes the third party talent which sells it hard to poor naïve retail and fund baskets / day traders. In return for these execs being allowed to participate in such a cushy position, they are required to allot part of the cash raises to research for researches sake, paying fees to universities and hospitals. The rest is split between execs and financiers.

This biotech game has been going on since the nineties from what I can tell. Under this kind of public company system the drug biologic commercialization rate is abysmal.

But that's not to say there aren't legitimate players out there, as we've seen some fantastic medicine and stock appreciation. It a shame the legit don't weed out the illegitimate but that's how research gets paid, I guess. And, the SEC just doesn't have the manpower or understanding to catch them at the game.

PS - I'm still on the fence with this company. Management seems like a mess but the their T product makes sense and looks good. Although I do question their ability to defend the patents.